Ambu A/S (AMBU B.CO) Osake Kurssi
Ambu A/S Kurssi
Viimeisten 19 vuoden aikana Ambu A/Sn liikevaihto kasvoi 11,9 % vuodessa ja ylsi 6,04 Mrd. DKK:een. Osakekohtainen tulos on kasvanut 14,2 % vuodessa viimeisten 19 vuoden aikana. Ambu A/Sn nettomarginaali 10,1 % on noussut verrattuna 6,2 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 0,52 %. Jakosuhde on noin 18 % tuloksesta. Osinko on kasvanut 6,5 % vuodessa viimeisten 19 vuoden aikana. Ambu A/Sn 12 kuukauden konsensustavoitehinta on 122,40 DKK, noin yli kurssia 56,2 %. 12 analyytikosta 9 suosittaa ostoa — kokonaiskonsensus on Osta.
Ambu A/S osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Ambu A/S liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Ambu A/S -osakkeesta
Ambu A/S is primarily present in various countries and regions worldwide. With its global presence, Ambu A/S operates in several key markets, including Europe, North America, and Asia-Pacific. The company's products and services cater to customers across numerous geographies, facilitating access to innovative medical solutions. Ambu A/S leverages its extensive international network to deliver high-quality healthcare devices and support healthcare professionals in improving patient outcomes. With a strong presence in multiple countries and regions, Ambu A/S demonstrates its commitment to serving customers and driving advancements in medical technology on a global scale.
Ambu A/S is a Danish company specializing in the development, manufacturing, and marketing of medical devices. Its business model revolves around providing innovative solutions for healthcare professionals, with a focus on respiratory care and patient monitoring. Ambu offers a wide range of high-quality products, such as flexible endoscopes, anesthesia devices, and single-use consumables. By combining expertise in engineering, medical science, and digital technology, Ambu aims to improve patient care, enhance clinical efficiency, and reduce healthcare costs. With a commitment to continuous research and development, Ambu strives to provide medical professionals with state-of-the-art solutions that prioritize patient safety and comfort.
Ambu A/S is primarily active in the medical device industry.
The main competitors of Ambu A/S in the market include Medtronic, Philips Healthcare, and Smiths Medical.
Ambu A/S is a Danish company specializing in medical devices and equipment. Established in 1937, Ambu has a rich history and a strong background in the healthcare industry. The company's focus lies in developing innovative solutions for diagnostics and patient monitoring, including products such as endoscopes and anesthesia masks. Ambu has a global presence, with operations in more than 120 countries and partnerships with various healthcare providers. Over the years, Ambu has earned a reputation for its high-quality products and commitment to improving patient care. With its extensive experience and expertise, Ambu A/S continues to be a leading player in the medical technology sector.
Some significant milestones achieved by Ambu A/S include continuous innovation in the field of single-use endoscopy, leading to the development of Ambu® aScope™, an innovative solution for visualizing the airways. The company has also achieved global recognition for their breakthrough product, Ambu® BlueSensor™ electrodes, which are used in monitoring patient vital signs during surgery. Ambu A/S has expanded its presence across multiple countries, establishing a strong global footprint. Moreover, the company has received several prestigious awards, including the Red Dot Design Award and the Medical Design Excellence Award, affirming their commitment to providing high-quality medical devices.
Ambu A/S represents a corporate philosophy based on certain key values. These values include innovation, quality, and a focus on improving patient outcomes. Ambu aims to provide innovative medical solutions that enhance the efficiency and safety of medical procedures. The company strives to maintain a high standard of quality in its product offerings, ensuring reliability and accuracy for healthcare professionals. Ambu's mission is to enable medical professionals to make better decisions and improve patient care. With a commitment to these values, Ambu A/S aims to be a trusted leader in the medical device industry.
Analyytikot asettavat tällä hetkellä Ambu A/S-osakkeelle keskimääräisen tavoitehinnan 121,52 DKK (mediaani: 122,40 DKK), mikä merkitsee +55,1 % viimeisimpään hintaan verrattuna. Konsensus perustuu 12 analyytikkoarvioon.
12 analyytikkoa arvioi tällä hetkellä Ambu A/S-osaketta: 9 suosittaa ostoa, 3 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Ambu A/S-yhtiöltä 6,44 Mrd. DKK liikevaihtoa ja 2,10 DKK osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Ambu A/S-osake noteerataan hintaan 10,48 EUR (78,35 DKK).
Ambu A/S-osake (AMBU B.CO) on listattuna 7 pörssissä, muun muassa: London (0MJF.L), Frankfurt (547A.F), München (547A.MU), Düsseldorf (547A.DU), Kopenhagen (AMBU-B.CO).
Ambu A/S is a Danish company specializing in the development, production, and marketing of medical products. It was founded in 1937 and is headquartered in Copenhagen. The company has branches in various parts of the world. Ambu is focused on three main business areas: anesthesia, patient monitoring, and diagnostics. In the anesthesia field, Ambu offers devices and instruments used in anesthesia procedures, including laryngeal tubes, masks, and ventilator bags. In patient monitoring, Ambu provides a range of products, including electrodes for measuring brain activity, accessories for EKG and pulse oximetry, and non-invasive blood pressure monitors. In the diagnostics field, Ambu offers endoscopes used in the examination of body cavities and internal organs. The company follows a business model focused on innovation and technological advancement. It invests a significant portion of its revenue in research and development to bring new and improved products to the market that meet customer requirements and contribute to improving medical care. Ambu also emphasizes high product quality and safety throughout the value chain, from development and production to marketing and customer support. In addition to product sales, Ambu provides comprehensive support and training opportunities to its customers, building strong long-term relationships. Overall, Ambu is a leading company in the field of medical technology, dedicated to improving medical care through innovative and effective products.
odotettu liikevaihto Ambu A/S on 6,44 Mrd. DKK. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Ambu A/S on 562,73 M DKK. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Ambu A/S:n hinta-voitto-suhde (P/E) on tällä hetkellä 37,34. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Ambu A/S-osakkeen arvostusta.
Ambu A/S:n hinta-myynti-suhde (P/S) on tällä hetkellä 3,26. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Ambu A/S-osakkeen arvostuskennuslukuna.
Ambu A/S:n Eulpool-laatuscore on 7/10.
Ambu A/S:n ISIN on DK0060946788. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Ambu A/S:n WKN on A2JAHY. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Ambu A/S:n ticker on AMBU B.CO. Tämä pörssinoteeraus käytetään Ambu A/S-osakkeiden kauppaan pörssissä.
Ambu A/S osake
Kaikki tunnusluvut ja syvällinen analyysi Ambu A/S:sta
Meidän osakeanalyysimme Ambu A/S-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Ambu A/S:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: